Ireland: White Smoke Emerges: New Medical Device Regulations Finally Published

Last Updated: 22 June 2016
Article by Colin Kavanagh, Orla M. Clayton and Ciara Farrell
Most Read Contributor in Ireland, July 2019

Initiated against the backdrop of the well-documented PIP breast implant issues, the new Regulations have been the subject of rigorous scrutiny and comment for the past four years. On 14 June 2016, the agreed texts of the Regulations were finally published on the Parliament's website which brings us closer to, arguably, the biggest legislative overhaul in the history of the medical device industry.

Further to our previous alert on this issue, below are some of the key elements of the new Regulations on medical devices and in vitro medical devices.


The definition of medical devices is expanded to include, amongst others, devices with purposes related to prediction and prognosis of diseases. This will have a significant impact on quantification products and services in the field of health-related parameters which could now fall within the scope of the new Regulations. Companies operating in the mHealth sector would also be advised to bear in mind any potential impact the draft European Commission guidelines on mHealth may have on their products.

The Regulations will also apply to a group of products without an intended medical purpose that are listed in Annex XV, such as contact lens, equipment for liposuction and products used for tattooing. These products will have to meet common specifications that address risk management and, where necessary, clinical evaluations regarding safety.


Reprocessing represented one of the most contentious points during the negotiations with some stakeholders strongly in favour of allowing reprocessing by default while others were strongly against such activities without the consent of the individual Member States.

Reprocessing refers to enabling a device to be safely reused through cleaning, disinfection, sterilisation and related procedures, including testing and restoration of the technical and functional safety of the previously used device.

According to the text of the new Regulations, reprocessing of devices will only be permitted in accordance with individual Member State legislation which may prohibit such reprocessing. The Commission is tasked with drawing up a report within four years after the date of application of the Regulations on the operation of these provisions and submit it to the European Parliament and to the Council for consideration.


The Regulations will further tighten the rules for the independent bodies that are responsible for assessing medical devices before they can be placed on the market (the so-called "notified bodies"). The Regulations introduce stricter designation requirements for these bodies and it remains to be seen whether current notified bodies will have the capability and competence to meet these new requirements.

The rules will give these bodies the right and duty to carry out unannounced factory inspections. While this is something that is happening already, companies need to be prepared for this type of "dawn raid".


Controversially, certain high-risk devices, such as implants, may undergo an additional check by experts before they are placed on the market.

The conformity assessment procedure for these devices can include the intervention of expert panels, designated by the European Commission. Notified bodies may seek advice from an expert panel on applications for conformity assessment for such devices. The notified body shall give due consideration to the views expressed by the expert panel.

Where the expert panel raises concerns about certain matters such as the sufficiency in the level of clinical evidence or serious concerns about the benefit/risk determination of the device, the notified body is required to advise manufacturers to take certain action to address those concerns. In the event that the notified body has not followed the advice of the expert panel, the notified body shall provide a full justification.

In addition to the above procedure, a newly created Medical Device Coordination Group ("MDCG") and, where applicable, the European Commission, may independently request scientific advice from the expert panels in relation to the safety and performance of any such high risk devices.


Manufacturers will be required to place a Unique Device Identification ("UDI") on their medical devices to ensure traceability. The UDI will need to be included on the label of the device. Entities involved will be able to identify from whom and to whom a device has been supplied in a "one step back"-"one step forward" approach.

The UDI will include information concerning the identity of the device, any warnings, precautions or measures to be taken by the patient or a healthcare professional and a description of potential adverse events.


With a backdrop of increasing transparency in the area of clinical trials for medicinal products, the new Regulations aim to improve the availability of clinical investigation data on devices.

Sponsors of clinical investigations will be required to publish the results of clinical investigations and a summary of the results in layman's language on Eudamed which will be available to the public. Eudamed is a database for information on medical devices collected by competent authorities and the European Commission. Presently, only such competent authorities and the European Commission have access to Eudamed. The Regulations will now grant access to Eudamed to a broader spectrum of stakeholders, including members of the public.

These documents must be published on Eudamed regardless of the outcome of the investigation and must be done within one year from the end of the investigation or within three months from its early termination or halt, whichever is the earliest.


The Regulations still have to be formally adopted by the Council and the Parliament which is expected to be completed by the end of this year following legal review and language translations in the coming months. It is widely anticipated that the Regulations will be adopted without any major alterations to their current form.

The new rules will apply three years after publication for medical devices and five years after publication for in vitro diagnostic medical devices.

This article contains a general summary of developments and is not a complete or definitive statement of the law. Specific legal advice should be obtained where appropriate.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Related Topics
Related Articles
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions